Our research study is being done to determine if a stimulant medication (Vyvanse) and behavioural therapy (contingency management) can help people stop or reduce their methamphetamine use. Altogether, your participation will be up to 24 weeks. People who take part in the research study will receive treatment for 15 weeks. During this time, you will come to our downtown Toronto clinic weekly. There is also a follow-up visit after one month of completing treatment.
Eligibility Criteria
- Age Range: 18-55 years old
- Use methamphetamine regularly,
- Are interested in reducing or stopping use, and
- Are able to communicate in English
What does the study involve?
- Number of contacts: 10+ sessions
- Format of Study: In-person
- Compensation offered: Yes
Investigator(s): Dr. Bernard Le Foll
Full Study Title: Addition of high dose stimulant and engagement-focused contingency
management, alone and in combination, to treatment as usual for the
management of methamphetamine use disorder (ASCME): a pan-Canadian multi
centre, randomized, controlled trial
Contact Information:
E-mail: ASCME.Study@camh.ca
REB number: 083/2023
REB Approval Expiry Date: February 27, 2027
PLEASE NOTE:
- Research staff cannot give medical advice over the phone or via email.
- If you have specific questions regarding your health care, please contact your family physician.
- We regret that not everyone screened for a study will be eligible to participate
- For more information about other treatment options for mental illness or addiction offered by CAMH, visit www.camh.ca or call 416-535-8501.